Clinical Trials on Childhood Malignant Peripheral Nerve Sheath Tumor
Total 2168 results
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
CelgeneCompletedMelanoma | Sarcoma, Soft Tissue | Cancer | Fibrosarcoma | Neuroblastoma | Osteogenic Sarcoma | Rhabdomyosarcoma | Neoplasm | Malignant Melanoma | Tumors | Histiocytoma | Dermatofibrosarcoma | Sarcoma, Ewing's | Neoplasia | Ewing's Sarcoma | Ewing's Tumor | Sarcomas, Epitheliod | Sarcoma, Spindle Cell | Clinical Oncology | Oncology,... and other conditionsUnited States, Canada, Spain, France, United Kingdom, Italy, Switzerland
-
Xinhua Hospital, Shanghai Jiao Tong University...Children's Neuro-Oncology Group (CNOG)UnknownMedulloblastoma, ChildhoodChina
-
University Hospital, Strasbourg, FranceUnknown
-
Manchester University NHS Foundation TrustCompletedNeurofibromatosis Type 2United Kingdom
-
PTC TherapeuticsUnited States Department of DefenseTerminated
-
Centre Hospitalier Universitaire de NiceUnknownNeurofibromatosis 2 | Dermatology/Skin - OtherFrance
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis | Neurofibromatosis 2 | Schwannomatosis | Neurofibromatosis IUnited States
-
Massachusetts Eye and Ear InfirmaryRecruiting
-
Massachusetts General HospitalRecruitingNeurofibromatoses | Neurofibromatosis 1 | Neurofibromatosis 2 | SchwannomatosisUnited States
-
The Children's Tumor FoundationRecruitingNeurofibromatosis 1 | Neurofibromatosis 2 | SchwannomatosisUnited States
-
National Institute of Neurological Disorders and...Recruiting
-
FDA Office of Orphan Products DevelopmentCochlearCompleted
-
Fachklinik Hornheide an der Universität MünsterWestfälische Wilhelms-Universität Münster; Deutsche RentenversicherungCompletedQuality of Life | Work Ability | Malignant Melanoma of SkinGermany
-
NYU Langone HealthNovartis Pharmaceuticals; The Children's Tumor FoundationCompletedNeurofibromatosis Type IIUnited States
-
Markus JoergerRecruiting
-
Assistance Publique - Hôpitaux de ParisNational Cancer Institute (NCI)Recruiting
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
Ultimovacs ASAActive, not recruitingMalignant MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Medical University of GrazCompleted
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Immunocore LtdTerminated
-
Genentech, Inc.Completed
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Hoffmann-La RocheCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
Hoffmann-La RocheCompleted
-
Hadassah Medical OrganizationUnknown
-
Merck Sharp & Dohme LLCTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia